Featured Programs

ASH 2015 Coverage: Emerging Approaches for Treatment-Resistant CML Patients

At the 2015 ASH meeting, Carol Preston visited with CML expert Dr. Kathryn Kolibaba to discuss progress for CML patients who are Gleevec resistant.


Patient Advocate Perspective: Stopping CML Treatment After Remission

During the 2014 American Society of Hematology (ASH) annual meeting, Patient Power caught up with our friend, Jan Geissler, a patient advocate living with CML 2001. Jan shares his perspective on the future of CML.


Love and Medicine Conquer CML

When 32-year-old Christopher was diagnosed with CML, he gave his fiancé the chance to "bow out."


Featured Blog
Ms. Pollyanna, Meet Mr. Negativity

By C.J. Chris

Page last updated on February 1, 2017